MedDataX Logo

Cardiovascular Risk Factors in an Ambulatory Urban Patient Population

NCT ID: NCT00486993

Last Updated: 2016-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18287 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-05-31

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

According to WHO estimations, cardiovascular diseases (CVDs) are the number one cause of death globally. More people die annually from CVDs than from any other cause. An estimated 17.5 million people died from CVDs in 2005, representing 30% of all global deaths. Of these deaths, an estimated 7.6 million were due to coronary heart disease and 5.7 million were due to stroke.

Over 80% of CVD deaths take place in low- and middle-income countries and occur almost equally in men and women. In Paraguay, prevalence of classic risk factors, as well as new ones, like the metabolic syndrome are not completely known.

Government health policies in industrialized countries are focusing on programs to modify cardiovascular risk factors. In developing countries, prevention of coronary heart disease and stroke through modification of cardiovascular risk factors are not playing a large role at the moment.

The aim of this study is to define the effects of changes in lifestyle on cardiovascular risk factors, when added to optimized standard pharmacological therapy for arterial hypertension, diabetes mellitus and hyperlipidemia, in an ambulatory urban patient population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Risk Factors Metabolic Syndrome Lifestyle Modification Coronary Artery Disease Stroke

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Diet Exercise Smoking Stress Polyphenols

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

asuriesgo

unselected outpatient population

Dietary and nutritional modification

Intervention Type BEHAVIORAL

Stop smoking

Intervention Type BEHAVIORAL

Regular physical activities

Intervention Type BEHAVIORAL

Weight reduction to normal ranges

Intervention Type BEHAVIORAL

Regular intake of polyphenols, esp. from Ilex paraguayensis

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary and nutritional modification

Intervention Type BEHAVIORAL

Stop smoking

Intervention Type BEHAVIORAL

Regular physical activities

Intervention Type BEHAVIORAL

Weight reduction to normal ranges

Intervention Type BEHAVIORAL

Regular intake of polyphenols, esp. from Ilex paraguayensis

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all ambulatory patients, with age 18 years or older
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Heidelberg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Derliz Mereles

Head Echocardiography Laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Derliz Mereles, MD

Role: PRINCIPAL_INVESTIGATOR

Heidelberg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Central Instituto de Prevision Social

Asunción, Dep. Central, Paraguay

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Paraguay

References

Explore related publications, articles, or registry entries linked to this study.

Jimenez JT, Palacios M, Canete F, Barriocanal LA, Medina U, Figueredo R, Martinez S, de Melgarejo MV, Weik S, Kiefer R, Alberti KG, Moreno-Azorero R. Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay. Diabet Med. 1998 Apr;15(4):334-8. doi: 10.1002/(SICI)1096-9136(199804)15:43.0.CO;2-Z.

Reference Type BACKGROUND
PMID: 9585400 (View on PubMed)

Ramirez MO, Pino CT, Furiasse LV, Lee AJ, Fowkes FG. Paraguayan National Blood Pressure Study: prevalence of hypertension in the general population. J Hum Hypertens. 1995 Nov;9(11):891-7.

Reference Type BACKGROUND
PMID: 8583468 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.asuriesgo.de

Internet site of the study

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AsuRiesgo

Identifier Type: -

Identifier Source: org_study_id